1. Market Research
  2. > Therapy Market Trends
  3. > Insulin Industry

Insulin Industry Statistics

You might be interested in: Diabetes, Hospital, Cardiovascular Disease, Food, Health Care Provider, Therapy, Antidiabetics, Hormone, Anti-Infective, Biguanide, Antiviral, Opioid, Monoclonal Antibody, Glucagon Like Peptide 1 Receptor Activator, Gliptins, Cardiovascular Drug, Hepatitis Treatment, HIV Antiviral, Statins, Analgesic.

1-7 of about 200 reports for Insulin

Global Insulin Market

  • February 2017
    115 pages
  • Insulin  

    Obesity  

    Blood Disease  

  • World  

    United States  

    Asia  

View report >

Insulin Market and Type 2 Diabetes Statistics in the US

  • January 2017
    16 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Insulin Market in the US and Europe - Forecast

  • November 2016
    5 pages
  • Insulin  

    Antidiabetics  

  • United States  

    Europe  

View report >

Diabetes Statistics and Insulin Market in Australia and China - Forecast

  • January 2017
    5 pages
  • Diabetes  

    Insulin  

    Antidiabetics  

  • Australia  

    China  

View report >

Insulin and Anti-Infective Market in the UK

  • February 2016
    17 pages
  • Insulin  

    Anti-Infective  

    Biosimilar  

  • United Kingdom  

View report >

Insulin Market in India

  • January 2016
    14 pages
  • Insulin  

  • India  

    Asia  

View report >

Insulin and Cardiovascular Drug Market in Canada

  • March 2016
    6 pages
  • Insulin  

    Cardiovascular ...  

    Food  

  • Canada  

View report >
About 300 reports for Insulin

Purchase Reports From Reputable Market Research Publishers
(From $ 75 - $ 19349)

Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017

Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017

  • $ 1450
  • Industry report
  • March 2017
  • by Delve Insight

DelveInsight’s, “Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2017” discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars ...

Insuline Medical Ltd

March 2017 $ 87

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.